Daily Programme

Tuesday, 28 October 2014

Global Tuberculosis Symposium

The Global Tuberculosis Symposium is organised by the World Health Organization (WHO) and is open to all delegates, free of charge; no badge is required to access the meeting room.

Further information on the Global Tuberculosis Symposium will be available shortly.

Global Tuberculosis Symposium

DATE: Tuesday, 28 October 2014

TIME:  09:00 - 17:00

ROOM:  112

The Global Tuberculosis Symposium is organised by the World Health Organization (WHO) and is open to all delegates; no badge is required to access the meeting room.

Background: For a world free of TB, out-of-the-box action is needed that builds on the fundamentals of quality TB prevention, care and control.

In May 2014, the World Health Assembly approved the World Health Organization's Post-2015 Global TB Strategy, which aims to end the global TB epidemic by 2035 with an associated 95% decline in TB deaths, a 90% decline in TB incidence and the elimination of catastrophic costs for TB-affected households.  Core actions of the strategy are framed under three pillars:

1. Integrated patient-centred care and prevention

2. Bold policies and supportive systems

3. Intensified research and innovation.

The strategy was developed through broad-based consultations with countries, partner organisations, civil society and academic experts.  Among these consultations were two previous Union World Conference on Lung Health symposia, which focused  in 2012 on framing the overall targets and strategic framework and, in 2013, on elaborating on the elements of its third pillar on research.

Building on these events, the Global TB Symposium in 2014 proposes to address how the strategy now can be taken forward through country adaptation. The strategy will fail if it is formulaically applied in all settings.  Defining the right course for adaptation in 2015, and initiating a rapid pace for implementation from early 2016, will be essential.   Business as usual won't suffice.   Out-of-the-box actions being taken by some governments, partners and communities today demonstrate that the unusual is possible.

Objectives of the symposium:

1. To offer participants an overview of the epidemiologic, programmatic and political context that set the baseline for implementing the new global TB strategy;

2. To provide examples of locally-specific applications using the innovative elements of the strategy and global support.



I.  Introduction

9h00 – 9h25



Moving out-of-the-Box: Introduction

José Luis Castro, The Union


Mario Raviglione, WHO

9:25 – 9:50

Global TB care and control: current progress

Katherine Floyd, WHO

9:50 – 10:15

Pursuing the global TB strategy within  post-2015 global health diplomacy

Ambassador Eric Goosby,  University of California, San Francisco, UCSF

10:15 – 10:20

The role of Parliamentarians in driving progress towards 2035 targets

Rt. Hon. Nick Herbert, Member of Parliament, United Kingdom

10:20 – 10:40



10:40 – 11:10

Coffee Break


11:10 – 11:15

II. Adopting and adapting the strategy

Co-chairs: Cheri Vincent, US Agency for International Development

                Catherina van Weezenbeek, Royal Netherlands TB Foundation

11:15 – 11:35

Setting the course to 2035: a national perspective

Viet Nhung Nguyen, Ministry of Health, Vietnam

11:35 – 11:50

A framework towards TB elimination for low-incidence countries

Knut Lonnroth, WHO

11:50 – 12:05

 Framing a response that fits the epidemic: epidemiology and engagement

Ibrahim Abubakar

Sarah Anderson

Public Health England   

12:05 – 12:30



12:30 – 13:30



13:30 – 13:35

III.  Pillar 1: Integrated, patient-centred care & prevention

Co-Chairs: Lucy Chesire, TB Advocacy Consortium

                   Malgosia Grzemska, WHO

13:35 – 13:50

Getting to universal rapid diagnosis & drug-susceptibility testing:  what will it take?

Catharina Boehme, Foundation for Innovative New Diagnostics, FIND

13:50 – 14:05

Patient-centred models of care: pursuing the mandate

Ernesto Jaramillo, WHO

Tajikistan National TB Programme & Médecins Sans Frontières

14:05 – 14:25

Moving on preventive therapy

Haileyesus Getahun, WHO

14:25 - 14:50




14:50 -14:55


IV: Pillar 2:  Bold policies and supportive systems

Co-Chairs:  Michael Johnson, The Global Fund

                    Diana Weil, WHO

15:00 - 15:15

Removing catastrophic patient costs with universal health coverage financing and social protection

Viorel Soltan, Center for Health Policies and Studies, Moldova

15:15 – 15:30

The carrot and the stick:  policy & regulation to reduce antimicrobial resistance

To be confirmed

15:30  - 15:45



15:45 - 16:10

Coffee break



16:10 – 16:15

V. Pillar 3:  Intensified research & innovation

Co-Chairs: Michael Kimerling, Bill & Melinda Gates Foundation

                   Christian Lienhardt, WHO

16:15 – 16:30

Panel: rolling out a policy implementation package for new TB drugs and regimens

Gavin Churchyard, Arum Institute Norbert Djeka, South Africa Department of Health

Dalene von Delft, TB PROOF

16:30 – 16:45

Collaboration for effective TB drug regimen trials

I.D. Rusen, The Union

16:45 – 17:00



17:00 – 17:05

VI.  Developing the global plan to Stop TB,  2016-2020: introduction

Paula Fujiwara, The Union and Chair of The Stop TB Partnership Task Force on the Global Plan to Stop TB

17:05 – 17:15

The importance of the Global Plan in achieving the post-2015 strategy

Aaron Motsoaledi, Minister of Health, South Africa

17:15 – 17: 35

The creation of the Global Plan, changes from previous plans, and complementarity to WHO’s post-2015 implementation guidelines

Jon Lidén, Suvanand Sahu

The Stop TB Partnership

17:35 – 17:45



17:45 – 17:55

VII. Kochon Prize Award Ceremony

Kochon Foundation, Stop TB Partnership

Chairman: Kim Doo-Hyun, Kochon Prize Foundation

                   Lucica Ditiu, Stop TB Partnership

17:55 – 18:00

VIII. Concluding remarks

Ambassador Eric Goosby, UCSF

Mario Raviglione, WHO


Union administrative meetings





Board Meeting 1



Meeting of Coordinating Committee of Scientific Activities (CCSA)



Editorial Board of Public Health Action



President’s Centennial Dinner

Place:  refer to the official invitation   


Tuesday, 28 October 2014


Time: 9:00-17:00

Room: 127/128                                                                       

Coordinator: Kayleigh Bleymann (UK)                  

Chair: Myra Wisotsky (USA)


World Health Organisation

Time: 14:30-17:00

Room: 129

The overall objective of this initiative is to create a technical platform for sharing, combining and interrogating TB clinical trial databases in an efficient, ethical and sustainable manner; and use recent data sets testing fluoroquinolones in first line TB therapy (RIFAQUIN, OFLOTUB, REMOX  trials) as a proof of principle for the merits of such a technical platform.

Coordinator: Corinne Merle (Switzerland)


Technical Exhibition


A scientific and technical exhibition showcasing a variety of companies, agencies, non-governmental organisations (NGOs), health organisations and manufacturers of materials and equipment.